These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 35205818)
1. Combination of Resminostat with Ruxolitinib Exerts Antitumor Effects in the Chick Embryo Chorioallantoic Membrane Model for Cutaneous T Cell Lymphoma. Karagianni F; Piperi C; Casar B; de la Fuente-Vivas D; García-Gómez R; Lampadaki K; Pappa V; Papadavid E Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205818 [TBL] [Abstract][Full Text] [Related]
2. Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma. Karagianni F; Piperi C; Valero-Diaz S; Amato C; Vaque JP; Casar B; Papadavid E Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335148 [TBL] [Abstract][Full Text] [Related]
3. Ruxolitinib with resminostat exert synergistic antitumor effects in Cutaneous T-cell Lymphoma. Karagianni F; Piperi C; Mpakou V; Spathis A; Foukas PG; Dalamaga M; Pappa V; Papadavid E PLoS One; 2021; 16(3):e0248298. PubMed ID: 33705488 [TBL] [Abstract][Full Text] [Related]
4. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma. Heider U; Rademacher J; Lamottke B; Mieth M; Moebs M; von Metzler I; Assaf C; Sezer O Eur J Haematol; 2009 Jun; 82(6):440-9. PubMed ID: 19220424 [TBL] [Abstract][Full Text] [Related]
5. Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Kamijo H; Miyagaki T; Shishido-Takahashi N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S Blood; 2018 Nov; 132(18):1922-1935. PubMed ID: 30194255 [TBL] [Abstract][Full Text] [Related]
6. Applying the chicken embryo chorioallantoic membrane assay to study treatment approaches in urothelial carcinoma. Skowron MA; Sathe A; Romano A; Hoffmann MJ; Schulz WA; van Koeveringe GA; Albers P; Nawroth R; Niegisch G Urol Oncol; 2017 Sep; 35(9):544.e11-544.e23. PubMed ID: 28551413 [TBL] [Abstract][Full Text] [Related]
7. Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma. Jimura N; Fujii K; Qiao Z; Tsuchiya R; Yoshimatsu Y; Kondo T; Kanekura T J Dermatol Sci; 2021 Mar; 101(3):194-201. PubMed ID: 33531202 [TBL] [Abstract][Full Text] [Related]
8. Extending the Applicability of Merlos Rodrigo MA; Casar B; Michalkova H; Jimenez Jimenez AM; Heger Z; Adam V Front Oncol; 2021; 11():707366. PubMed ID: 34540673 [TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma. Biskup E; Kamstrup MR; Manfé V; Gniadecki R Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313 [TBL] [Abstract][Full Text] [Related]
10. BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines. Kamijo H; Sugaya M; Takahashi N; Oka T; Miyagaki T; Asano Y; Sato S Arch Dermatol Res; 2017 Aug; 309(6):491-497. PubMed ID: 28593508 [TBL] [Abstract][Full Text] [Related]
12. Chick embryo chorioallantoic membrane model systems to study and visualize human tumor cell metastasis. Deryugina EI; Quigley JP Histochem Cell Biol; 2008 Dec; 130(6):1119-30. PubMed ID: 19005674 [TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis of Human Cancer Cell Extravasation Using Intravital Imaging. Willetts L; Bond D; Stoletov K; Lewis JD Methods Mol Biol; 2016; 1458():27-37. PubMed ID: 27581012 [TBL] [Abstract][Full Text] [Related]
14. The Chicken Egg Chorioallantoic Membrane (CAM) Model as an In Vivo Method for the Investigation of the Invasion and Metastasis Cascade of Malignant Tumor Cells. Leupold JH; Patil N; Allgayer H Methods Mol Biol; 2021; 2294():17-26. PubMed ID: 33742391 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of cancer metastasis using an avian embryo model. Palmer TD; Lewis J; Zijlstra A J Vis Exp; 2011 May; (51):. PubMed ID: 21673636 [TBL] [Abstract][Full Text] [Related]
16. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents. Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554 [TBL] [Abstract][Full Text] [Related]
18. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Nihal M; Ahmad N; Wood GS Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700 [TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma. Froehlich TC; Müller-Decker K; Braun JD; Albrecht T; Schroeder A; Gülow K; Goerdt S; Krammer PH; Nicolay JP Blood; 2019 Aug; 134(5):445-455. PubMed ID: 31167801 [TBL] [Abstract][Full Text] [Related]
20. Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells. Brouwer IJ; Out-Luiting JJ; Vermeer MH; Tensen CP Biochem Biophys Rep; 2020 Dec; 24():100832. PubMed ID: 33102814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]